Saturday 17 October 2026 Export IMDX’s income statement to Excel — free account

Insight Molecular Diagnostics Inc.

Insight Molecular Diagnostics Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.1 million, up 115.6% from fiscal 2024. In the quarter to June 2026, revenue fell 53.9%, EPS fell 3.33% and free cash flow fell 54.0%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.

3.01 0.05 −1.63%

Follow IMDX

Alert me

Market cap: $100.1M
P/E: 0.0×
Fwd P/E: −6.4×
Dividend yield: —
F-score: 3/9
Altman Z: −25.63
Beneish M: −7.73
Dividend safety: n/a

Overview Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	5	4	2	1
ROE Full definition →		(23,500.97%)	229.65%	20,228.75%	488.68%
ROA Full definition →		(106.02%)	(165.10%)	(94.93%)	(123.46%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(338.53%)	(519.57%)	(174.46%)	(303.54%)
Average Days of Receivables Full definition →		21.39	101.53	29.40	41.96
Free Cash Flow per Share Full definition →		(0.75)	(0.83)	(0.80)	(0.84)
Free Cash Flow Full definition →		(23.91)	(25.37)	(27.47)	(31.00)
Capital Expenditures Full definition →		(1.92)	(3.18)	(3.49)	(3.92)
Other line items
Cash ROIC Full definition →		(233.80%)	145.28%	(150.64%)	1,632.39%
Accounts Receivable Turnover Full definition →		18.85	2.96	1.05	4.74
Accounts Payable Turnover Full definition →		2.08	0.84	0.49	0.55
Inventory Turnover Full definition →		5.70	4.11	2.29	1.92
Average Days of Payables Full definition →		192.24	528.49	613.40	791.33
Days of Inventory on Hand Full definition →		85.74	92.65	145.09	87.55
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		280.05%	392.11%	919.91%	1,146.47%
Selling, General and Administrative Expense of Revenue Full definition →		366.20%	418.64%	926.01%	1,121.56%
Share Based Compensation of Revenue Full definition →		45.37%	54.72%	121.14%	150.78%
Interest Coverage Full definition →		(542.62)	(469.03)	(473.18)	(513.24)
Operating CF/Net income Full definition →		0.36	0.44	0.50	0.55
Depreciation/Fixed assets Full definition →		0.53	0.34	0.26	0.41
Capex/Depreciation Full definition →		(0.87)	(1.45)	(1.49)	(1.60)
Revenue per Share Full definition →		0.14	0.13	0.06	0.05
Operating CF per Share Full definition →		(0.69)	(0.73)	(0.69)	(0.74)
Capex per Share Full definition →		(0.06)	(0.10)	(0.10)	(0.11)
Capex to Sales Full definition →		0.44	0.79	1.79	2.35

Show all line items

Columns are period end dates

Stockrow Weekly